RxBio rxbio.com


Public lists: Pharma Startups (4732)

RxBio is a biotech company based on a broad platform of novel and proprietary technology. Recently, a primary focus of RxBio has been developing its lead compound, Rx100, for use in mitigation of gastro-intestinal acute radiation syndrome (GI-ARS). GI-ARS follows exposure to potentially lethal ionizing radiation. GI-ARS occurs as a result of nuclear-weapon detonation, during manufacture and development of nuclear energy materials and following nuclear accidents.

RxBio is a biotech company based on a broad platform of novel and proprietary technology. Recently, a primary focus of RxBio has been developing its lead compound, Rx100, for use in mitigation of gastro-intestinal acute radiation syndrome (GI-ARS). G...Show all

Company (Alive / Active)

Phone: 423-928-3330

Fax:

1325 Sunset Drive

Johnson City, 37604
Tennessee, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
RxBio $2.2M Jul 21, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related RxBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed - II, Unattributed
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Dec 12, 2014 Feb 14, 2017 Patent
Lpa receptor agonists and antagonists Mar 03, 2009 Apr 01, 2014 Patent
Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Feb 10, 2017 Application
Immunosuppressive compounds and therapeutics Jul 23, 2014 Application